Federation Des Caisses Desjardins Du Quebec Viking Therapeutics, Inc. Transaction History
Federation Des Caisses Desjardins Du Quebec
- $18.9 Billion
- Q3 2024
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 15,710 shares of VKTX stock, worth $841,584. This represents 0.01% of its overall portfolio holdings.
Number of Shares
15,710
Previous 8,910
76.32%
Holding current value
$841,584
Previous $472,000
110.59%
% of portfolio
0.01%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding VKTX
# of Institutions
468Shares Held
66.2MCall Options Held
5.32MPut Options Held
3.03M-
Vanguard Group Inc Valley Forge, PA10.2MShares$545 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$323 Million0.01% of portfolio
-
State Street Corp Boston, MA4.67MShares$250 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.12MShares$113 Million0.01% of portfolio
-
Morgan Stanley New York, NY1.87MShares$100 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $4.11B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...